Plasmodium falciparum infection can interfere with the immune response to BK-SE36 malaria vaccine
27 April 2023 Malaria remains a major health challenge, particularly in sub-Saharan Africa, where children under five face the greatest...
top of page
NEWS
News
Search
EVI
- Apr 25
- 2 min
World Malaria Day 2023
On April 25th, we celebrate World Malaria Day and reflect on the progress that has been made in the fight against malaria. This year's theme
EVI
- Apr 24
- 2 min
Protecting the next generations with vaccines – World & European Immunization Week 2023
23-30 April 2023 The World Immunization Week (WIW), running from 24-30 April and European Immunization Week (EIW), running from 23-29...
EVI
- Mar 13
- 1 min
Leishmaniasis - a Forgotten Epidemic
March 2023 Written by the leishmaniasis team at the European Vaccine Initiative (EVI), an article entitled “Leishmaniasis — a Forgotten...
EVI
- Feb 10
- 2 min
International day of women and girls in science
February 11, 2023 The International Day of Women and Girls in Science is celebrated to acknowledge the achievements of women in science...
EVI
- Jan 27
- 2 min
World NTD Day 2023: Act now. Act together.
NTDs are often overlooked and neglected due to their prevalence in low-income countries and the lack of resources available to combat them.
EVI
- Jan 20
- 2 min
Antibody response to BK-SE36 vaccination is not impacted by African-specific SERA5 polymorphisms
SEmalvac: new study demonstrates that antibody response to BK-SE36 vaccination is not impacted by African-specific SERA5 polymorphisms.
EVI
- Dec 27, 2022
- 2 min
International day of epidemic preparedness 2022
The International Day of Epidemic Preparedness recognises the importance of being prepared for, and responding to, public health emergencies
EVI
- Dec 20, 2022
- 2 min
Dutch government pledges €17 Mio to EVI to advance malaria vaccines for pregnant women and children
The Netherlands Enterprise Agency awarded 17 Mio Euro to EVI. This is part of the Product Development Partnerships IV Fund.
EVI
- Dec 19, 2022
- 2 min
The WHO/TDR alumni meeting brings together EVI fellows in Cape Town
The WHO/TDR Clinical Research & Development Fellowships alumni meeting was held in Cape Town.
EVI
- Dec 5, 2022
- 3 min
Protecting the next generations with vaccines
Fighting diseases of poverty & preventing emerging infections with vaccines - Joint film by EVI, GSK, iBET, Moderna and Vaccines Europe.
EVI
- Nov 29, 2022
- 2 min
Latest results from EVI-led projects ShigEtecVax and ShigaPlexIM to be presented at the VASE 2022
The latest results from two projects coordinated by EVI will be presented at the VASE conference 2022 to be held in Washington.
EVI
- Nov 18, 2022
- 2 min
WAAW 2022: antimicrobial resistance, one of the biggest threats to human health
The World Antimicrobial Awareness Week (WAAW) occurs every year between 18 and 24 November.
EVI
- Nov 2, 2022
- 2 min
Novel blood-stage malaria vaccine candidate, adjuvanted PfRipr5, to reach over 50% in vitro efficacy
Plasmodium falciparum is a highly complex pathogen that causes malaria. Protective malaria vaccine approaches can target three...
EVI
- Sep 5, 2022
- 2 min
Blood-stage malaria vaccine candidate BK-SE36 shown to be safe and immunogenic in children
Malaria is a major public health concern, particularly among children in Sub-Saharan Africa.
EVI
- Aug 30, 2022
- 4 min
EVI's new publication identifies gaps in outreach information on COVID-19 vaccine trials in Europe
31 August 2022 Together with VACCELERATE partners, European Vaccine Initiative (EVI) just published the main findings of the new freely...
EVI
- Aug 18, 2022
- 3 min
VAC2VAC, ‘Vaccine batch to vaccine batch comparison by consistency testing,’ successfully completed
The VAC2VAC project (1 March 2016 - 28 February 2022) was dedicated to developing quality control testing approaches for human and...
EVI
- Jul 5, 2022
- 2 min
Asexual blood-stage malaria vaccine candidate PfRipr5: enhanced production in insect cells
05 July 2022 Malaria is a potentially fatal disease caused by parasites transferred to humans through the bites of infected female...
EVI
- Jun 13, 2022
- 3 min
New European-African partnership to contribute to the fight against placental malaria
€10 million mobilised by the ADVANCE-VAC4PM consortium to advance the development of a safe, effective, and affordable placental malaria...
EVI
- May 30, 2022
- 2 min
ShigETEC vaccine candidate against diarrhoeal disease proved to be safe in phase I clinical trial
30 May 2022 Diarrhoea is one of the most common diseases, globally, affecting children under five years of age. Although typically being...
EVI
- Apr 25, 2022
- 2 min
“Vaccines provide everyone a chance at a fulfilling life”
World Immunization Week: 24 – 30 April 2022 For more than two centuries, vaccines have helped keep people healthy—from the very first...
EVI
- Apr 25, 2022
- 3 min
World Malaria Day 2022: harness innovation to reduce the malaria disease burden and save lives
Every year on April 25th, the World Malaria Day takes place as an internationally recognised date and an opportunity to commemorate and...
EVI
- Apr 10, 2022
- 1 min
EVI joining CEPI-funded programme for development of broadly protective betacoronaviruses vaccines
We are delighted to announce that CEPI, the Coalition for Epidemic Preparedness Innovations has awarded US$200m to advance the...
EVI
- Mar 31, 2022
- 3 min
A dose of teamwork against pandemics: TRANSVAC
Collaboration is key to developing vaccines. Merck's article highlights why collaboration in vaccine manufacturing learning is key to...
bottom of page